Tessellate BIO
Pre-clinicalAt Tessellate Bio, we are exploring new synthetic lethal interactions beyond Homologous Recombination Deficiency (HRD), uncovering novel biology and mechanisms to create a pipeline of first-in-class precision medicines that address significant unmet needs for patients.
Founded
2021
Focus
ProteomicsDrug Discovery
About
At Tessellate Bio, we are exploring new synthetic lethal interactions beyond Homologous Recombination Deficiency (HRD), uncovering novel biology and mechanisms to create a pipeline of first-in-class precision medicines that address significant unmet needs for patients.
Company Info
TypePrivate
Founded2021
LocationLeiden, Netherlands
StagePre-clinical
Contact
SIMILAR COMPANIES
2-BBB Medicines
Pre-clinical · Leiden
Batavia Biosciences
Pre-clinical · Leiden
Bilthoven Biologicals
Pre-clinical · Bilthoven
Agendia
Pre-clinical · Amsterdam
Alloksys Life Sciences
Phase 2 · Wageningen
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile